Evidence map›Paper›PMID 42494268›Full record

ArticleYonsei medical journal2026

Pharmacogenetic Risk Factors for Thiopurine-Induced Leukopenia in Patients with Inflammatory Bowel Disease.

Eun Kyung Boo, Jongwook Yu, Sohyung Oh, Jae Hee Cheon, Ju Han Kim

Erratum issuedAbstract read
In one paragraph

Article in Yonsei medical journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors.

Eun Kyung Boo *Seoul National University Biomedical Informatics (SNUBI), Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0009-0006-9104-8473
Jongwook Yu *Department of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0001-7489-2222
Sohyung OhDepartment of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0009-0009-7096-7122
Jae Hee CheonDepartment of Internal Medicine and Institute of Gastroenterology, Yonsei University College of Medicine, Seoul, Korea. GENIUSHEE@yuhs.ac.ORCID https://orcid.org/0000-0002-2282-8904
Ju Han KimSeoul National University Biomedical Informatics (SNUBI), Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, Korea.ORCID https://orcid.org/0000-0003-1522-9038

Funding

Korean Association of Internal Medicine ResearchNational Research Foundation of Korea 2023R1A2C3007686Seoul National University Hospital
6 · The paper itself

Abstract

purposeThiopurines remain an effective treatment for maintaining remission in inflammatory bowel disease (IBD), yet their use is often limited by thiopurine-induced leukopenia (TIL), a potentially life-threatening adverse effect. We aimed to investigate pharmacogenetic associations with TIL in patients with IBD. MATERIALS AND

methodsWe retrospectively analyzed 218 thiopurine-treated patients from two independent IBD cohorts with whole-exome sequencing. Pharmacogenetic subgroups were defined using Clinical Pharmacogenetics Implementation Consortium star allele-based molecular phenotypes or genotype-based classifications. Genetic associations with TIL, defined as white blood cell count ≤3000/µL, were analyzed using Andersen-Gill models adjusted for clinical covariates.

results

conclusionOur findings confirm the central role of

Indexed as

Inflammatory Bowel DiseasesLeukopeniaMercaptopurineAdultAzathioprineFemaleGenotypeHumansInterleukin-6MaleMethyltransferasesMiddle AgedNudix HydrolasesPharmacogeneticsPyrophosphatasesRetrospective StudiesAzathioprineInterleukin-6MercaptopurineMethyltransferasesNudix HydrolasesNUDT15 protein, humanPyrophosphatasesInflammatory bowel diseaseleukopeniapharmacogeneticsprecision medicine

Identifiers

PMID42494268
PMCPMC13407061

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.